Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Syneron Medical Company Profile (NASDAQ:ELOS)

Consensus Ratings for Syneron Medical (NASDAQ:ELOS) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $14.85 (47.61% upside)

Analysts' Ratings History for Syneron Medical (NASDAQ:ELOS)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/16/2014Leerink SwannLower Price Target$17.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
4/23/2014ZacksDowngradeOutperform -> Neutral$13.40ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014ZacksUpgradeNeutral -> Outperform$13.40ViewTweet This Rating  Share This Rating on StockTwits
2/3/2014Leerink SwannBoost Price Target$17.00ViewTweet This Rating  Share This Rating on StockTwits
11/18/2013ZacksUpgradeUnderperform -> Neutral$12.30ViewTweet This Rating  Share This Rating on StockTwits
11/14/2013Cantor FitzgeraldReiterated RatingBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
11/14/2013Griffin SecuritiesBoost Price TargetBuy$12.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
11/11/2013Leerink SwannReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
9/13/2013Cantor FitzgeraldLower Price TargetBuy$16.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2013ZacksDowngradeNeutral -> Underperform$8.00ViewTweet This Rating  Share This Rating on StockTwits
8/15/2013Griffin SecuritiesLower Price TargetBuy$15.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
2/7/2013TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
10/12/2012Griffin SecuritiesInitiated CoverageBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
10/4/2012Cantor FitzgeraldReiterated RatingBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/22/2012 forward)